AmericanPeptide
Research areas/Longevity & Aging
Research area · 20 peptides

Longevity & Aging

Peptides studied across the aging axis — senescence, NAD+, and resilience.

Overview

Longevity research examines peptides that act on the hallmarks of aging: cellular senescence, mitochondrial decline, telomere maintenance, NAD+ metabolism, and the gradual loss of circadian and hormonal regulation. The goal in most models is healthspan — preserving function — rather than a single disease endpoint.

Compounds studied here often originate as endogenous regulatory peptides whose expression falls with age. Because aging endpoints are slow and multifactorial, this area leans heavily on biomarker studies, model organisms, and mechanistic work rather than large outcome trials.

Peptides studied in longevity & aging

Myostatin (GDF-8)

The body’s brake on muscle growth — a TGF-β-family growth factor whose inhibition is the leading strategy to preserve muscle, including during GLP-1 weight loss.

View profile

Follistatin

A natural myostatin and activin antagonist — by neutralizing the muscle brake it is one of the most potent pro-muscle factors studied, and a doping and gene-therapy flashpoint.

View profile

MOTS-c

Mitochondrially-encoded peptide with reported insulin-sensitizing activity.

View profile

Humanin

A 24-amino-acid mitochondrial-derived peptide with cytoprotective, anti-apoptotic activity — a companion to MOTS-c on the mitochondrial-signaling frontier.

View profile

Epitalon

Synthetic tetrapeptide investigated for telomerase activity and circadian effects.

View profile

Endoluten

The natural pineal peptide bioregulator — the animal-derived counterpart to synthetic Epitalon, marketed for aging and telomere support.

View profile

FOXO4-DRI

A senolytic D-retro-inverso peptide that selectively triggers apoptosis in senescent cells by disrupting the FOXO4–p53 interaction.

View profile

Thymalin

Thymus-derived polypeptide complex — the founding tissue bioregulator (Cytomax) studied for immune restoration.

View profile

Vilon

Synthetic Lys-Glu dipeptide — the defined short-peptide successor to Thymalin, studied for immune and aging endpoints.

View profile

Vesugen

Synthetic Lys-Glu-Asp tripeptide studied as a vascular-axis bioregulator.

View profile

Pinealon

Synthetic Glu-Asp-Arg tripeptide studied as a brain/CNS bioregulator.

View profile

Cardiogen

Synthetic Ala-Glu-Asp-Arg tetrapeptide studied as a cardiac-tissue bioregulator.

View profile

Pancragen

Synthetic Lys-Glu-Asp-Trp tetrapeptide studied as a pancreas-tissue bioregulator.

View profile

Testagen

Synthetic Lys-Glu-Asp-Gly tetrapeptide studied as a testis / reproductive-tissue bioregulator.

View profile

Prostamax

Synthetic Lys-Glu-Asp-Pro tetrapeptide studied as a prostate-tissue bioregulator — the defined-sequence successor to older prostate extracts.

View profile

Vladonix

A natural thymus peptide complex (Cytomax A-6) — the extract-based counterpart to Thymalin, marketed for immune support and aging.

View profile

Ventfort

A natural blood-vessel peptide complex (Cytomax A-3) — the extract-based counterpart to Vesugen, targeting vascular tissue.

View profile

Chelohart

A natural heart-muscle peptide complex (Cytomax A-14) — the extract-based counterpart to Cardiogen, targeting cardiac tissue.

View profile

5-Amino-1MQ

Small-molecule NNMT inhibitor (often catalogued alongside peptides).

View profile

NAD+

Essential redox cofactor central to mitochondrial bioenergetics and sirtuin activity.

View profile

Frequently asked questions

What does longevity peptide research target?+

The hallmarks of aging — cellular senescence, mitochondrial decline, telomere maintenance, NAD+ metabolism, and loss of circadian and hormonal regulation — usually with healthspan as the goal.

Why are outcomes hard to measure?+

Aging endpoints are slow and multifactorial, so research relies on biomarkers, model organisms, and mechanistic work rather than large outcome trials.

Where do these peptides come from?+

Many are endogenous regulatory peptides whose expression falls with age, studied as candidates to restore more youthful signaling.

Understand the evidence

How to weigh this evidence

Preclinical, observational, and randomized findings carry very different weight. The evidence hierarchy shows how to rank what you read before drawing conclusions.

Hands-on tools

Put the science to work — interactive utilities that run right here.

Peptide Agent

Ask the Agent about Longevity & Aging

Which peptides are best studied for longevity & aging, how they compare, and what the clinical evidence shows — citation-backed answers grounded in PubMed, PubChem, and ClinicalTrials.gov.